Microcoat now offering Assay Development and Sample Measurement on MSD® Platform
Microcoat expands its technological portfolio by Meso Scale Discovery´s Electrochemiluminescence (MSD-ECL) platform. Based on non-radioactive electrochemiluminescent labels for ultra-sensitive detection, MSD yields higher sensitivity and broader dynamic range compared to ELISA technology. Microcoat offers development of assays from the scratch as well as transfer of classical ELISA formats in addition to method comparison, validation and sample measurement. Customers profit from our year-long experience in custom-fit optimization and manufacturing of antibody conjugates including MSD´s SULFO-Tag®.
MORE NEWS
- 03Nov
Microcoat announces the 7th Monocyte-Activation Test Proficiency Test Program
Read More → - 17Okt
Meet us at the PharmaLab 2022 Düsseldorf/Neuss, Germany
Read More → - 10Okt
Microcoat announces agreement with Olink to offer innovative proteomic approaches with Olink® Proximity Extension Assay (PEA) technology for pharma partners
Read More → - 29Sep
Meet us at the PDA 2022, Pharmaceutical Microbiology Conference in Washington DC
Read More → - 20Sep
Meet us at the Aseptikon 2022 Mannheim, Germany
Read More → - 22Jul
EU innovation radar launches SciFiMed project- MicroCoat proud to be part of the project!
Read More → - 05Mai
Microcoat announces the 6th Monocyte-Activation Test Proficiency Test Program
Read More → - 14Apr
30 Years Microcoat
Read More → - 10Mrz
Donation handover Ahrtal
Read More → - 21Okt
We are back!
Read More →
